REVIVA PHARMACEUTCLS HLDGS I
Q1 2026 13F Holders
Symbol
RVPH
CUSIP
76152G209
Type
Equity
Class
COM NEW
Num filings
37
Total reported value, excl. options
$2.13 M
Compare 2026 Q1 to
2026 Q3
2026 Q2
2025 Q4
Manager
Report Date
Value ($000)
Shares
Option Type